CONMED Corporation (CNMD) by event type
CNMD moves most on analyst downgrades — a median of +0.47% at 30 minutes across 20 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CNMD overview →
How CNMD reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,359 of 2,717 | 16 | +0.00% | 50% | +0.04% |
| Analyst downgrades 405 of 2,603 | 20 | +0.47% | 60% | -0.76% |
| Rating reiterations 451 of 3,522 | 46 | +0.20% | 54% | -0.44% |
| Price-target cuts 288 of 1,527 | 28 | +0.15% | 54% | -0.26% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how CNMD usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target cuts → · CNMD overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CorMedix Inc. (CRMD) | 269 | -0.42% | 39% |
| Verrica Pharmaceuticals Inc. (VRCA) | 269 | -0.01% | 46% |
| Codexis, Inc. (CDXS) | 267 | 0.00% | 51% |
| CytomX Therapeutics, Inc. (CTMX) | 267 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.